Implementation of Support in the Care of Adults Living With Type 1 Diabetes

Summary

The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the "Support" platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration "Support" in clinical care.

Conditions

• Type 1 Diabetes
• Metabolic Disease
• Endocrine System Diseases
• Autoimmune Diseases
• Immune System Diseases

Interventions

BEHAVIORAL

Support platform

The study will be conducted over a 12-month period. This should allow participants to see their medical team 2 to 3 times during this timeframe. Participants of arms 1 and 2 will have access to the Support platform and will receive a monthly newsletter, informing them of news on the platform and acting as a reminder to log in. Several features are included in this responsive-designed platform to enhance participation, such as a visual of personal progress, ability to bookmark content, change their avatar. Support contains 3 main components: Educational material, News blog written by HCPs weekly in collaboration with patient-partners on up-to-date topics related to T1D, a peer-to-peer discussion forum which is moderated daily by a HCP specializing in T1D.

Sponsors & Collaborators

• Institut de Recherches Cliniques de Montreal

  collaborator OTHER

• Centre Hospitalier de l'Universite Laval (CHUL)

  collaborator UNKNOWN

• Centre hospitalier de l'Université de Montréal (CHUM)

  collaborator OTHER

• Centre de médecine métabolique de Lanaudière

  collaborator UNKNOWN

• McGill University

  lead OTHER

Principal Investigators

• Anne-Sophie Brazeau, PhD · School of human nutrition - McGill University

Study Design

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-05-05

Primary Completion

2027-05-05

Completion

2027-10-31

Countries

• Canada

Study Locations